Using herbs medically without knowing their composition: are we playing Russian roulette?

References

• Fears R, Griffin GE, Larhammar D, et al. Globalization of traditional Chinese medicine: what are the issues for ensuring evidence-based diagnosis and therapy? J Intern Med. 2020;287(2):210–213.
   PubMed Web of Science ®Google Scholar
• This Week. More scrutiny for herbal remedies. Nature. 2017;551:541.
   Web of Science ®Google Scholar
• Zhang X. WHO traditional medicine strategy 2002–2005. Geneva, Switzerland: World Health Organization; 2002.
   Google Scholar
• Zhang Q, Sharan A, Espinosa SA, et al. The path toward integration of traditional and complementary medicine into health systems Globally: The World Health Organization Report on the Implementation of the 2014–2023 strategy. J Altern Complement Med. 2019;25(9):869–871.
   PubMed Web of Science ®Google Scholar
• Nahin RL, Barnes PM, Stussman BJ. Expenditures on complementary health approaches: United States, 2012. Natl Health Stat Report. 2016; 95:1–11.
   Google Scholar
• Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. Jama. 1998;280(18):1569–1575.
   PubMed Web of Science ®Google Scholar
• Laiyemo MA, Nunlee-Bland G, Lombardo FA, et al. Characteristics and health perceptions of complementary and alternative medicine users in the United States. Am J Med Sci. 2015;349(2):140–144.
   PubMed Web of Science ®Google Scholar
• Selmar D, Radwan A, Hijazin T, et al. Horizontal natural product transfer: intriguing insights into a newly discovered phenomenon. J Agric Food Chem. 2019;67(32):8740–8745.
   PubMed Web of Science ®Google Scholar
• Tu Y. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat Med. 2011;17(10):1217–1220.
   PubMed Web of Science ®Google Scholar
• Pless IB, Huang RS, Ding XQ, et al. 2011 Lasker-DeBakey clinical medical research award, 2015 Nobel prize in physiology or medicine. In: Ing TS, Lau KK, Chan JM, et al. editors. Nobel and lasker laureates of Chinese descent: in literature and science. Singapore: World Scientific Publishing; 2019.
   Google Scholar
• FDA provides update on its ongoing investigation into ARB drug products; reports on finding of a new nitrosamine impurity in certain lots of losartan and product recall. 2019; [cited 2021 Jan 15]. Available from: http://www.fda.gov/news-events/press-announcements/fda-provides-update-its-ongoing-investigation-arb-drug-products-reports-finding-new-nitrosamine.
   Google Scholar
• Smith L, Ernst E, Ewings P, et al. Co-ingestion of herbal medicines and warfarin. Br J Gen Pract. 2004; 54:439–441.
   PubMed Web of Science ®Google Scholar
• Hurly D. Natural causes – death, lies, and politics in America’s vitamin and herbal supplement industry. New York: Broadway Books; 2006.
   Google Scholar
• Vanherweghem JL, Depierreux M, Tielemans C, et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet. 1993;341(8842):387–391.
   PubMed Web of Science ®Google Scholar
• Yang HY, Chen PC, Wang JD. Chinese herbs containing aristolochic acid associated with renal failure and urothelial carcinoma: a review from epidemiologic observations to causal inference. Biomed Res Int. 2014; 2014:569325.
   PubMed Web of Science ®Google Scholar
• Wen CP, Cheng TY, Tsai MK, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet. 2008;371(9631):2173–2182.
   PubMed Web of Science ®Google Scholar
• Grollman AP, Shibutani S, Moriya M, et al. Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc Natl Acad Sci USA. 2007; 104(29):12129–12134.
   PubMed Web of Science ®Google Scholar
• Brown AC. Kidney toxicity related to herbs and dietary supplements: online table of case reports. Part 3 of 5 series. Food Chem Toxicol. 2017;107(Pt A):502–519.
   PubMed Web of Science ®Google Scholar
• Zhang H, Ding X, Tai KB, et al. Alternative medicine and chinese herbs and the kidney. In: Ronco C, Bellomo R, Kellum JA, Ricci Z. Critical care nephrology, 3rd ed. Philadelphia PA: Elsevier; 2017. p. 1313–1319.
   Google Scholar
• De Smet PA. Herbal remedies. N Engl J Med. 2002;347(25):2046–2056.
   PubMed Web of Science ®Google Scholar
• Quan NV, Xuan D, Teschke R. Potential hepatotoxins found in herbal medicinal products: a systematic review. Int J Mol Sci. 2020;21(14):5011.
   PubMed Web of Science ®Google Scholar
• Selmar D, Wittke C, Beck-von Wolffersdorff I, et al. Transfer of pyrrolizidine alkaloids between living plants: a disregarded source of contaminations. Environ Pollut. 2019;248:456–461.
   PubMed Web of Science ®Google Scholar
• Teschke R, Vongdala N, Quan NV, et al. Metabolic toxification of 1,2-unsaturated pyrrolizidine alkaloids causes human hepatic sinusoidal obstruction syndrome: the update. Int J Mol Sci. 2021;22(19):10419.
   PubMed Web of Science ®Google Scholar
• Stedman C. Herbal hepatotoxicity. Semin Liver Dis. 2002;22(2):195–206.
   PubMed Web of Science ®Google Scholar
• Woolf GM, Petrovic LM, Rojter SE, et al. Acute hepatitis associated with the Chinese herbal product Jin bu Huan. Ann Intern Med. 1994;121(10):729–735.
   PubMed Web of Science ®Google Scholar
• Nadir A, Agrawal S, King PD, et al. Acute hepatitis associated with the use of a Chinese herbal product, ma-huang. Am J Gastroenterol. 1996;91(7):1436–1438.
   PubMed Web of Science ®Google Scholar
• Furbee RB, Barlotta KS, Allen MK, et al. Hepatotoxicity associated with herbal products. Clin Lab Med. 2006;26(1):227–241.
   PubMed Web of Science ®Google Scholar
• Stickel F, Patsenker E, Schuppan D. Herbal hepatotoxicity. J Hepatol. 2005;43(5):901–910.
   PubMed Web of Science ®Google Scholar
• Navarro VJ, Barnhart H, Bonkovsky HL, et al. Liver injury from herbals and dietary supplements in the U.S. drug-induced liver injury network. Hepatology. 2014;60(4):1399–1408.
   PubMed Web of Science ®Google Scholar
• Danan G, Bénichou C. Causality assessment of adverse reactions to drugs – I. A novel method based on the conclusions of international consensus meeting: application to drug-induced liver injuries. J Clin Epidemiol. 1993;46(11):1323–1330.
   PubMed Web of Science ®Google Scholar
• Bénichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs. – II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol. 1993;46(11):1331–1336.
   PubMed Web of Science ®Google Scholar
• Liver Tox: clinical and research information on drug-induced liver injury [Internet]. Roussel Uclaf Causality Assessment Method (RUCAM) in drug induced liver injury. Last update May 4, 2019.
   Google Scholar
• Danan G, Teschke R. RUCAM in drug and herb induced liver injury: the update. Int J Mol Sci. 2015;17(1):14.
   PubMed Web of Science ®Google Scholar
• Teschke R, Danan G. Worldwide use of RUCAM for causality assessment in 81,856 idiosyncratic Dili and 14,029 HILI cases published 1993-Mid 2020: a comprehensive analysis. Medicines. 2020;7(10):62.
   Google Scholar
• Teschke R, Zhu Y, Jing J. Herb-induced liver injury in Asia and current role of RUCAM for causality assessment in 11,160 published cases. J Clin Transl Hepatol. 2020;8(2):200–214.
   PubMed Web of Science ®Google Scholar
• Teschke R, Danan G. Idiosyncratic drug-induced liver injury (DILI) and herb-induced liver injury (HILI): diagnostic algorithm based on the quantitative Roussel Uclaf Causality Assessment Method (RUCAM). Diagnostics. 2021;11(3):458.
   Web of Science ®Google Scholar
• Melchart D, Hager S, Albrecht S, et al. Herbal traditional Chinese medicine and suspected liver injury; a prospective study. World J Hepatol. 2017;9(29):1141–1157.
   PubMedGoogle Scholar
• Nelson L, Shih R, Hoffman R. Aplastic anemia induced by an adulterated herbal medication. J Toxicol Clin Toxicol. 1995;33(5):467–470.
   PubMed Web of Science ®Google Scholar
• He J, Du L, Liu G, et al. Quality assessment of reporting of randomization, allocation concealment, and blinding in traditional Chinese medicine RCTs: a review of 3159 RCTs identified from 260 systematic reviews. Trials. 2011;12:122.
   PubMed Web of Science ®Google Scholar
• Teschke R, Wolff A, Frenzel C, et al. Herbal traditional Chinese medicine and its evidence base in gastrointestinal disorders. World J Gastroenterol. 2015;21(15):4466–4490.
   PubMed Web of Science ®Google Scholar
• Li X, Yang G, Li X, et al. Traditional Chinese medicine in cancer care: a review of controlled clinical studies published in Chinese. PLoS One. 2013;8(4):e60338.
   PubMed Web of Science ®Google Scholar
• Cheng CW, Wu TX, Shang HC, et al. CONSORT extension for Chinese herbal medicine formulas 2017: recommendations, explanation, and elaboration. Ann Intern Med. 2017;167(2):112–121.
   PubMed Web of Science ®Google Scholar
• Linde K, Brinkhaus B. Randomized trials of Chinese herbal medicine: a new extension of the CONSORT statement. Ann Intern Med. 2017;167(2):133–134.
   PubMed Web of Science ®Google Scholar
• Nobel Renews Debate on Chinese Medicine – The New York Times, Author: Ian Johnson; [cited 2015 Oct 10]. Available from: https://www.nytimes.com/2015/10/11/…/nobel-renews-debate-on-chinese-medicine.html
   Google Scholar
• Boseley S. Doctors call for tighter regulation of traditional Chinese medicine. The Guardian, Nov 6 2019.
   Google Scholar
• France-Presse A. Traditional Chinese medicine must face same regulations as Western methods, European doctors demand. SCMP, Nov 8, 2019.
   Google Scholar
• Lian F, Li G, Chen X, et al. Chinese herbal medicine Tianqi reduces progression from impaired glucose tolerance to diabetes: a double-blind, randomized, placebo-controlled, multicenter trial. J Clin Endocrinol Metab. 2014;99(2):648–655.
   PubMed Web of Science ®Google Scholar
• Chen Y, Fu DY, Chen Y, et al. Effects of Chinese herbal medicine Yiqi Huaju Formula on hypertensive patients with metabolic syndrome: a randomized, placebo-controlled trial. J Integr Med. 2013;11(3):184–194.
   PubMedGoogle Scholar
• Li P, Chen Y, Liu J, et al. Efficacy and safety of tangshen formula on patients with type 2 diabetic kidney disease: a multicenter double-blinded randomized placebo-controlled trial. PLoS One. 2015;10(5):e0126027.
   PubMed Web of Science ®Google Scholar
• Ge Y, Xie H, Li S, et al. Treatment of diabetic nephropathy with Tripterygium wilfordii Hook F extract: a prospective, randomized, controlled clinical trial. J Transl Med. 2013;11(1):134.
   PubMed Web of Science ®Google Scholar
• Yang G, Zhang M, Zhang M, et al. Effect of Huangshukuihua (Flos Abelmoschi Manihot) on diabetic nephropathy: a meta-analysis. J Tradit Chin Med. 2015;35(1):15–20.
   PubMed Web of Science ®Google Scholar
• Kua KP, Lee SWH. Complementary and alternative medicine for the treatment of bronchiolitis in infants: a systematic review. PLoS One. 2017;12(2):e0172289.
   PubMed Web of Science ®Google Scholar
• Parker S, Zhang CS, Yu JJ, et al. Oral Chinese herbal medicine versus placebo for psoriasis vulgaris: a systematic review. J Dermatolog Treat. 2017;28(1):21–31.
   PubMed Web of Science ®Google Scholar
• Wang J, Chen N, Fang L, et al. A systematic review about the efficacy and safety of Tripterigium wilfordii Hook F. preparation used for the management of rheumatoid arthritis. Evid Based Complement Alternat Med. 2018;2018:1567463.
   PubMed Web of Science ®Google Scholar
• Billings W, Mathur K, Craven HJ, et al. Potential benefit with complementary and alternative medicine in irritable bowel syndrome: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2021;19(8):1538–1553.
   PubMed Web of Science ®Google Scholar
• Chao J, Dai Y, Verpoorte R, et al. Major achievements of evidence-based traditional Chinese medicine in treating major diseases. Biochem Pharmacol. 2017;139:94–104.
   PubMed Web of Science ®Google Scholar
• Atanasov AG, Zotchev SB, Dirsch VM, et al. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021;20(3):200–216.
   PubMed Web of Science ®Google Scholar